Facebook Pixel How AI is Redefining Talent and Innovation in Life Sciences | Bio Spectrum – business – Lesen Sie diese Geschichte auf Magzter.com

Versuchen GOLD - Frei

How AI is Redefining Talent and Innovation in Life Sciences

Bio Spectrum

|

December 2025

AI's future in life sciences will be driven by hybrid expertise, continuous upskilling, and strong collaboration across academia, industry, and clinical practice to build a smarter, more responsive healthcare ecosystem.

How AI is Redefining Talent and Innovation in Life Sciences

Much like other sectors, AI has become indispensable in the life sciences sector, accelerating progress in healthcare, pharmaceuticals, genomics, and biotechnology.

To put things in perspective, the global AI market in the pharmaceutical industry is projected to reach $16.49 billion by 2034, while AI in the medical devices segment is expected to scale up to $97.1 billion by 2028, fuelled by the widespread use of AI-powered diagnostic systems, smart wearables, and surgical robotics. Across this fast-changing landscape, AI professionals are becoming the most sought-after by organisations in the life sciences segment. These experts are redefining how diseases are diagnosed, drugs are discovered, and care is delivered. For India’s life sciences ecosystem, this is both an opportunity and an inflexion point; one where the convergence of biology, data, and machine learning is opening up entirely new career frontiers. That said, it’s essential for the existing workforce in this field, as well as aspirants, to understand just how the job landscape is likely to evolve and the challenges it may present.

Rise of AI-driven healthcare and drug discovery roles

WEITERE GESCHICHTEN VON Bio Spectrum

Bio Spectrum

Bio Spectrum

Can India's CDMOS Lead the Next Biopharma Wave?

India's Contract, Development, and Manufacturing Organisation (CDMO) sector is projected to grow from $3-3.5 billion today to $22-25 billion by 2035, noted Boston Consulting Group (BCG).

time to read

8 mins

March 2026

Bio Spectrum

Bio Spectrum

Telangana turns catalyst for innovation

Telangana is at a pivotal moment in its journey as a global life sciences hub.

time to read

6 mins

March 2026

Bio Spectrum

Bio Spectrum

Is AI the New Weapon in the Fight to End TB?

A report released at the India AI Impact Summit 2026, organised by the Government of India, reveals that artificial intelligence (AI) is being successfully deployed at scale across India’s public healthcare system to address the growing burden of tuberculosis (TB).

time to read

2 mins

March 2026

Bio Spectrum

Bio Spectrum

ChemWerth on-boards Chandrakanth Reddy as new GSM to increase generic API footprint in India

US-based ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

Beyond the Glass Ceiling: Women-Led Companies Shaping India's Health Economy

Over the past decade, women entrepreneurs have gained strong ground in India's healthcare sector, building ventures in diagnostics, FemTech, biotech, and care delivery.

time to read

5 mins

March 2026

Bio Spectrum

Bio Spectrum

"There needs to be a collaborative effort between innovators and policymakers to create frameworks that ensure safety without stifling progress"

Started in 2021, Decode Age, one of the pioneers in Longevity Research in India, entered its next phase of growth following its Pre-Series A funding round, led by Granules India.

time to read

5 mins

March 2026

Bio Spectrum

Bio Spectrum

Rainbow Children's Medicare appoints Abrarali Dalal as Chief Executive Officer

Rainbow Children's Medicare, a leading provider of paediatrics, perinatal, and women's healthcare services in India, has announced the appointment of Abrarali Dalal as Chief Executive Officer, effective from January 20, 2026.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

Haleon ropes in Kedar Lele as President for India Subcontinent

Haleon, a British multinational consumer healthcare company has announced the appointment of Kedar Lele as President for India Subcontinent (ISC), effective January 2026.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

Centre revises Startup Recognition Framework to strengthen Startup India Action Plan

The government of India has revamped the Startup Recognition Framework to further strengthen the Startup India Action Plan and take forward the Prime Minister's vision of positioning India as a global innovation powerhouse, manufacturing-led economy and hub for emerging tech.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

"In the coming 5 years from now, no Indian CROS will grow or survive without the use of AI"

In January 2026, Ahmedabad-based Veeda Lifesciences announced a strategic leadership transition that marks a new chapter in the company's evolution.

time to read

5 mins

March 2026

Listen

Translate

Share

-
+

Change font size